Object
To investigate the effect of T2* correction on estimation of kinetic parameters from T1-weighted dynamic contrast enhanced (DCE) MRI data when a reference-tissue arterial input function (AIF) is used.
Materials and Methods
DCE-MRI data were acquired from 7 mice with 4T1 mouse mammary tumors using a double gradient echo sequence at 7T. The AIF was estimated from a region of interest in the muscle. The extended Tofts model was used to estimate pharmacokinetic parameters in the enhancing part of the tumor, with and without T2* correction of the lesion and AIF. The parameters estimated with T2* correction of both the AIF and lesion time-intensity curve were assumed to be the reference standard.
Results
For the whole population, there was significant difference (p<0.05) in transfer constant (Ktrans) between T2* corrected and not corrected methods, but not in interstitial volume fraction (ve). Individually, no significant differences were found in Ktrans and ve of four and six tumors, respectively, between the T2* corrected and not corrected methods. In contrast, Ktrans was significantly underestimated, if the T2* correction was not used, in other tumors of which median Ktrans was larger than 0.4 min−1.
Conclusion
T2* effect on tumors with high Ktrans may not be negligible in kinetic model analysis, even if AIF is estimated from reference tissue where the concentration of contrast agent is relatively low.